Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data

Autor: S. Adami, George A. Wells, Paul D. Miller, Ethel S. Siris, Jean-Yves Reginster, Jonathan D. Adachi, Cyrus Cooper, Ann Cranney, E. Yetisir, Socrates E. Papapoulos, Pierre D. Delmas, S. Silverman, Philip N. Sambrook

UNLABELLED: This analysis was conducted to assess the effect of high versus lower doses of ibandronate on nonvertebral fractures. The results were adjusted for clinical fracture, age, and bone density. The treatment effect was dose-dependent. Higher

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd814f3e2572ace49f326ffb34ecf619
https://ora.ox.ac.uk/objects/uuid:60cf463e-d9b9-47e6-9e2a-371a95827479

Zobrazit plný text záznamu

A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care

Autor: Martin Tweeddale, George A. Wells, John C. Marshall, E. Yetisir, Paul C. Hébert, I. Schweitzer, Morris A. Blajchman, Claudio Martin, G. Pagliarello

Publikováno v: New England Journal of Medicine. 340:409-417

BACKGROUND To determine whether a restrictive strategy of red-cell transfusion and a liberal strategy produced equivalent results in critically ill patients, we compared the rates of death from all causes at 30 days and the severity of organ dysfunct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c623714531f37c26c3b574ebc6bdc71d
https://doi.org/10.1056/nejm199902113400601

Zobrazit plný text záznamu

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]

Autor: J H, Noseworthy, G C, Ebers, M K, Vandervoort, R E, Farquhar, E, Yetisir, R, Roberts

Publikováno v: Neurology. 57(12 Suppl 5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3999cdb12d3da9a283f7ad1f9848e382
https://pubmed.ncbi.nlm.nih.gov/11902593

Zobrazit plný text záznamu

A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial

Autor: M, Man-Son-Hing, A, Laupacis, A M, O'Connor, J, Biggs, E, Drake, E, Yetisir, R G, Hart

Publikováno v: JAMA. 282(8)

Decision aids are tools designed to help patients participate in the clinical decision-making process.To determine whether use of an audiobooklet (AB) decision aid explaining the results of a clinical trial affected the decision-making process of stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ad8933c3b3b80d4ae3f4529a2a60a584
https://pubmed.ncbi.nlm.nih.gov/10463715

Zobrazit plný text záznamu

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Autor: P C, Hébert, G, Wells, M A, Blajchman, J, Marshall, C, Martin, G, Pagliarello, M, Tweeddale, I, Schweitzer, E, Yetisir

Publikováno v: The New England journal of medicine. 340(6)

To determine whether a restrictive strategy of red-cell transfusion and a liberal strategy produced equivalent results in critically ill patients, we compared the rates of death from all causes at 30 days and the severity of organ dysfunction.We enro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::af555b27f0c6a2205c67647bef784067
https://pubmed.ncbi.nlm.nih.gov/17203568

Zobrazit plný text záznamu

Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center

Autor: P C, Rowe, E, Orrbine, H, Lior, G A, Wells, E, Yetisir, M, Clulow, P N, McLaine

Publikováno v: The Journal of pediatrics. 132(5)

The objectives of this study were to better estimate the age-specific risks of hemolytic uremic syndrome (HUS) and hemolytic anemia after Escherichia coli O157:H7 infection among a representative cohort of both referred and nonreferred children with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ae1dd0639481de230a7ca490d4754c95
https://pubmed.ncbi.nlm.nih.gov/9602178

Zobrazit plný text záznamu

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial

Autor: R. E. Farquhar, Robin S. Roberts, George C. Ebers, M. K. Vandervoort, John H. Noseworthy, E. Yetisir

Publikováno v: Scopus-Elsevier

In the randomized, placebo-controlled, physician-blinded Canadian cooperative trial of cyclophosphamide and plasma exchange, neither active treatment regimens (group I: i.v. cyclophosphamide and prednisone; group II: weekly plasma exchange, oral cycl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c173035ac5b8081db051a65b04442359
https://pubmed.ncbi.nlm.nih.gov/8290055

Zobrazit plný text záznamu

A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG)

Autor: E. Yetisir, K. S. Robinson, D. P. Sheridan, Richard van der Jagt, L. M. Larratt, George A. Wells, R. Delage

Publikováno v: Blood. 106:4619-4619

Background: A CLSG pilot rx’d 140 pts.with Response Adapted Rx(RA) with Idarubicin 12 mg/m2 d1-3 & Ara-C 200 mg/m2 d1-7(IDAC);followed by IDAC II, then Mitoxantrone10 mg/m2&VP-16 100 mg/m2d1-5(NOVE), if in CR after IDAC, & NOVE x2 if they had persi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a3856687ad3eddd767599264cb763154
https://doi.org/10.1182/blood.v106.11.4619.4619

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání